Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Spinal Cord Neoplasms 1Pinealoma 1Lymphoma, Follicular 1Glioma 1Glioblastoma 1Choroid Plexus Carcinoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 4Automobiles 3fludarabine 2etoposide phosphate 2Nivolumab 2Etoposide 2Celecoxib 2tozuleristide 1perillyl alcohol 1omburtamab I-131 1Watchful Waiting 1Vincristine 1Thiotepa 1Temozolomide 1Tamoxifen 1Sirolimus 1Proton Therapy 1ONC206 1Mesna 1Isotretinoin 1Immunotherapy 1Hydrocortisone 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pinealoma × perillyl alcohol × 1 year × Clear all
NCT06357377 2026-01-14

A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

Neonc Technologies, Inc.

Phase 1 Not yet recruiting
12 enrolled
CNS

Choroid Plexus Carcinoma, Glioma, Pinealoma, Spinal Cord Neoplasms, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡